For long thought of as a net recipient of global health benefits, India is turning into a global healthcare provider. This will be a major pillar of its diplomacy in the years to come.
While the government rolled out the Covid-19 vaccination programme on January 16, questions of accessibility and affordability remain for sections of the population.
India began the first phase of the mass vaccination programme against Covid-19. Fortune India's photo team visited one session site in Gurugram where the campaign was in full swing.
The massive campaign to deploy the Covid-19 vaccine rests on infrastructure, both physical and digital. Using past campaigns, India put together a multi-pronged strategy for a smooth roll-out.
For BBIL’s founder Krishna Ella, the roll-out of a made-in-India vaccine, Covaxin, is peppered with challenges. Two recent deals with Brazilian and American firms have now buoyed him.
The preparations on the ground are in full swing, and the country is using the expertise and insights culled from its innumerable election processes to begin rolling out the Covid-19 vaccine.
The U.K. has given its nod for the AstraZeneca-Oxford vaccine. Back in India, the country is readying for a massive immunisation campaign. Here's a close look at the programme.
India is conducting dry runs for the Covid-19 vaccination programme. Fortune India visited one such site, following the trajectory of one health worker, depicting the entire vaccination process.
